BenchSci News

ASM and BenchSci Partner to Bring ASM Journal Content to Scientists Using EMET

ASM and BenchSci Partner to Bring ASM Journal Content to Scientists Using EMET

All 17 ASM journals, including their figures, become available to scientists working in EMET

Introducing the Hypothesis Generation Agent

Introducing the Hypothesis Generation Agent

Emet proposed two untested drug combinations for a cancer with no druggable driver. Both hypotheses were supported by initial in-vitro experimentation

BenchSci Partners with Google Cloud to Close Biology's Infrastructure Gap

BenchSci Partners with Google Cloud to Close Biology's Infrastructure Gap

Patsnap Now Available in BenchSci’s EMET as Companies Partner to Integrate Patent and Drug Development Intelligence into Unified Scientific Research Workflows

Patsnap Now Available in BenchSci’s EMET as Companies Partner to Integrate Patent and Drug Development Intelligence into Unified Scientific Research Workflows

ASM and BenchSci Partner to Bring ASM Journal Content to Scientists Using EMET

ASM and BenchSci Partner to Bring ASM Journal Content to Scientists Using EMET

BenchSci Announces Two-Year Enterprise Agreement with argenx to Advance AI-Driven Preclinical Drug Discovery

BenchSci Announces Two-Year Enterprise Agreement with argenx to Advance AI-Driven Preclinical Drug Discovery

BenchSci Partners with Google Cloud to Close Biology's Infrastructure Gap

BenchSci Partners with Google Cloud to Close Biology's Infrastructure Gap

BenchSci Names Former Pfizer R&D Chief Dr. Mikael Dolsten as Chairman of the Board

BenchSci Names Former Pfizer R&D Chief Dr. Mikael Dolsten as Chairman of the Board

BenchSci Extends ASCEND Agreement with Merck to Support Preclinical Disease Biology Research

BenchSci Extends ASCEND Agreement with Merck to Support Preclinical Disease Biology Research

BenchSci Ranked Among Fastest-Growing Companies in North America on the 2025 Deloitte Technology Fast 500™

BenchSci Ranked Among Fastest-Growing Companies in North America on the 2025 Deloitte Technology Fast 500™

BenchSci and Mila Partner to Advance AI for Biological Inference and Accelerate Drug Discovery

BenchSci and Mila Partner to Advance AI for Biological Inference and Accelerate Drug Discovery

BenchSci Announces Three-Year License Agreement with Sanofi to Access and Use BenchSci’s ASCEND Platform

BenchSci Announces Three-Year License Agreement with Sanofi to Access and Use BenchSci’s ASCEND Platform

Ready to experience it yourself?

Try EMET